Getting Even More Chai

I have substantially increased by exposure to cannabis in the last five trading sessions.

Should prices remain depressed, I expect to continue to add.

I am repeating this column from May that summarizes my constructive investment outlook for the sector (updates are bold-faced):

—–

8 Reasons I’m Getting More Positive on Cannabis

I am growing much more optimistic on the cannabis complex.

I plan to super-size (VL) my MSOS holdings and I plan to expand individual equity positions (with emphasis on GTBIF and VRNO).

I am doing so because:

* I am extremely confident that rescheduling of both medical and adult use (recreational) will pass in the next few months. (The rescheduling of medical use has already been passed.  Adult recreational use will likely follow in the next few months.) 

* I am confident that uplistings will soon follow. (Trulieve has become the first cannabis company to list – TerrAscend, Curaleaf and Verano have announced their intentions to uplist on either the NYSE or Nasdaq. After Trulieve, which cannabis MSO will be the next to uplist?)

* More relaxed custodian rules allowing for institutional purchases of the group. (Uplistings and rescheduling will hasten relaxation of the custody.)

* The recent debt refinancings have eliminated the frightening debt maturity cliff that some feared. (Every single cannabis company has followed up the refinancings with recently announced company share repurchases.)

* Industry fundamentals (volumes and pricing) have stabilized. (This has been confirmed by recent company reports.)

Expectations are very low. (And getting lower with a decline in share prices!)

* Massive absolute and relative underperformance over the last five years has created a long runway for appreciation.

* Upside reward is probably more than 5x downside risk. (With the decline in the space, the uplistings, buybacks and better business conditions, I would make that 6x.)

Position: Long MSOS common (L) and calls (S), VRNO (S), GTBIF (VS)    

BY DOUG KASS · May 27, 2026, 4:33 PM EDT

—–

The next catalyst will likely be a rescheduling of cannabis for recreational use.

Position: Long MSOS (L), VRNO (S), GTBIF (S), TRLV (S), TSNDF (VS)

Avatar photo

Posted by Doug Kass

Doug Kass is a world-renowned hedge fund manager with decades of experience and success navigating through some of the most turbulent periods in market history. He is known for his time-tested analytical skills and ability to look past the current noise and herd mentality. On TheStreet Pro, Kass provides frequent market commentary and investing ideas for active investors throughout each trading day in Doug’s Daily Diary. He also serves as president of Seabreeze Partners Management Inc. Previously, he served as a senior manager at Omega Advisors, a $6 billion investment partnership. He co-authored a book with Ralph Nader and the Center for the Study of Responsive Law called “Citibank: The Ralph Nader Report” and can be found as a guest host on CNBC's "Squawk Box." A Note from Doug: Current strategies and actionable trade ideas -- all on one dynamic platform built exclusively for active trades. From sudden sell-offs to sudden spikes, TheStreet Pro arms you with crucial analysis -- at a rapid fire, professional pace -- to help you make sound trading decisions -- every day, every hour, and every minute. Join me and my team of professional traders for unique perspectives and breakthrough investment opportunities.

Leave a Reply

Your email address will not be published. Required fields are marked *